Related Articles
Knockdown of ribonucleotide reductase regulatory subunit M2 increases the drug sensitivity of chronic myeloid leukemia to imatinib‑based therapy
Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma
Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy
Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma
Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma